Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine Prevention
Public ClinicalTrials.gov record NCT02483585. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the effect of erenumab compared to placebo on the change from baseline in monthly migraine days, in adults with episodic migraine.
Study identification
- NCT ID
- NCT02483585
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 577 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 20, 2015 (Actual)
- Primary completion
- Jul 11, 2016 (Actual)
- Completion
- Mar 20, 2017 (Actual)
- Last update posted
- Oct 12, 2022
2015 – 2017
United States locations
- U.S. sites
- 40
- U.S. states
- 28
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35216 | — |
| Research Site | Phoenix | Arizona | 85018 | — |
| Research Site | Culver City | California | 90230 | — |
| Research Site | Long Beach | California | 90806 | — |
| Research Site | Sacramento | California | 95821 | — |
| Research Site | San Diego | California | 92103 | — |
| Research Site | Santa Monica | California | 90404 | — |
| Research Site | Walnut Creek | California | 94598 | — |
| Research Site | Colorado Springs | Colorado | 80907 | — |
| Research Site | Fairfield | Connecticut | 06824 | — |
| Research Site | Hollywood | Florida | 33021 | — |
| Research Site | Jacksonville | Florida | 32216 | — |
| Research Site | Orlando | Florida | 32806 | — |
| Research Site | Oviedo | Florida | 32765 | — |
| Research Site | Palm Beach Gardens | Florida | 33410 | — |
| Research Site | Atlanta | Georgia | 30342 | — |
| Research Site | Gurnee | Illinois | 60031 | — |
| Research Site | Indianapolis | Indiana | 46256 | — |
| Research Site | Lenexa | Kansas | 66214 | — |
| Research Site | Lexington | Kentucky | 40513 | — |
| Research Site | Baltimore | Maryland | 21208 | — |
| Research Site | Boston | Massachusetts | 02131 | — |
| Research Site | Ann Arbor | Michigan | 48104 | — |
| Research Site | Kalamazoo | Michigan | 49009 | — |
| Research Site | Princeton | New Jersey | 08540 | — |
| Research Site | Albuquerque | New Mexico | 87102 | — |
| Research Site | Williamsville | New York | 14221 | — |
| Research Site | Asheville | North Carolina | 28806 | — |
| Research Site | Winston-Salem | North Carolina | 27103 | — |
| Research Site | Cincinnati | Ohio | 45245 | — |
| Research Site | Oklahoma City | Oklahoma | 73112 | — |
| Research Site | Philadelphia | Pennsylvania | 19114 | — |
| Research Site | Warwick | Rhode Island | 02886 | — |
| Research Site | Mt. Pleasant | South Carolina | 29464 | — |
| Research Site | Chattanooga | Tennessee | 37421 | — |
| Research Site | Austin | Texas | 78759 | — |
| Research Site | Dallas | Texas | 75214 | — |
| Research Site | Salt Lake City | Utah | 84121 | — |
| Research Site | Virginia Beach | Virginia | 23454 | — |
| Research Site | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02483585, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 12, 2022 · Synced Nov 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02483585 live on ClinicalTrials.gov.